Federico De Santis

MD, Neurologist, PhD Student in Experimental Medicine - Basic and Clinical Neurosciences,
University of L'Aquila
🧠

[Matteo Foschi @mattfos89]

A huge thank you to all coauthors and collaborators worldwide for their expertise, energy, and commitment 🌍💡@Simona_Sacco_
@luciodanna2 @FishingNeurons @ECSandset @SCouttsMD @PoojaKathri @fededs00 @univaq @AUSLRomagna

[Headache Journal @HeadacheJournal]

Open Access:
A cross-sectional study finds #sleep disturbance influences the relationship between #migraine frequency & #glymphatic dysfunction
https://t.co/9093fTQwlT
@RaffaeleOrnello @federicosalfi @fededs00 @alessandraSple2 @Simona_Sacco_

[Matteo Foschi @mattfos89]

🚨 Just published! 🚨

📄 Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis

https://t.co/afAonFsoDb

[Simona Sacco @Simona_Sacco_]

🎉 Congratulations to @fededs00, neurologist and PhD candidate at @univaq, for receiving the @ESOstroke Young Investigator Award! 👏🏻👏🏻👏🏻
A well-deserved recognition!
Kudos to Raffaele Ornello, Matteo Foschi and Eleonora De Matteis, key members of the project team. So proud! 💪🏻🧠

[Matteo Foschi @mattfos89]

New study! 🚨 @TANeurolDisord
In patients with minor #stroke or TIA, higher admission SBP is linked to⬆️ risks of early deterioration, recurrent vascular events, and 🩸 after #DAPT

@Simona_Sacco_ @fededs00 @luciodanna2 @RaffaeleOrnello @luciodanna2

https://t.co/WZH9biyObB

[Matteo Foschi @mattfos89]

🧠 💊 Just published in @ESOstroke Journal: DAPT in patients with minor stroke or TIA and cancer—what's the risk? 🚨  

@univaq @Simona_Sacco_ @RaffaeleOrnello @fededs00 @Eleonor32576320 @luciodanna2

https://t.co/vJunZ9abtp

[LAB-NEU @lab_neu2024]

📢#ASPERA study has been officialy presented at #ISA-stroke congress 2025 by @mattfos89 … ➡️DM us @mattfos89 @RaffaeleOrnello @Simona_Sacco_ @fededs00 to join the study @univaq @ISA_AII_Young

[ISAYoung @ISA_AII_Young]

New results from READAPT study @univaq @fededs00 @Simona_Sacco_ @mattfos89
#stroke #readapt

[Simona Sacco @Simona_Sacco_]

One recurring question I often get during lectures on migraine, stroke, and PFO is about the use of antithrombotic therapy. To address this, we conducted a systematic review. Curious about the findings? Read the full article below.

[Federico De Santis @fededs00]

@HeadacheJournal

[Federico De Santis @fededs00]

Just published!📜📢
We are pleased to present our systematic review about the current evidence on antithrombotic drugs in migraine prevention and potential future applications.
https://t.co/h8aELz1ur6
@mattfos89 @MicheleRomoli @ChiaraRosx @Simona_Sacco_ @RaffaeleOrnello

[European Headache Federation @EHF_Official]

Multi-center study provides new and encouraging real-world efficacy and safety data for rimegepant. https://t.co/Y4vzSdL0c6

[International Journal of Stroke @IntJStroke]

💊Short-term dual antiplatelet treatment may be safe and more effective than single antiplatelet treatment

🧑‍🤝‍🧑Study of 2,000+ participants

Read about it here👇
https://t.co/Y1h3rgNz6Z
@Simona_Sacco_ @mattfos89 @RaffaeleOrnello
@luciodanna2 @fededs00 @Eleonor32576320 @MicheleRomoli @ZiniAndrea @MlzZedde @giovmerl

[Matteo Foschi @mattfos89]

Ensure to follow the new page of our research lab and join us in many collaborative research projects for 2025 🤩 important news coming soon… stay tuned!! ➡️@Simona_Sacco_ @RaffaeleOrnello @fededs00 @ChiaraRosx @univaq

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: The READAPT study shows that women with non-cardioembolic mild-to-moderate stroke or high-risk TIA treated with DAPT may have lower short-term risk of recurrent ischemic events than men. #AHAJournals #GoRedForWomen @GoRedForWomen https://t.co/eupd48kFt3

[International Journal of Stroke @IntJStroke]

💊Short-term dual antiplatelet treatment may be safe and more effective than single antiplatelet treatment

🧑‍🤝‍🧑Study of 2,000+ participants

Read about it here👇
https://t.co/Y1h3rgNz6Z
@Simona_Sacco_ @mattfos89 @RaffaeleOrnello
@luciodanna2 @fededs00 @Eleonor32576320 @MicheleRomoli @ZiniAndrea @MlzZedde @giovmerl

[International Journal of Stroke @IntJStroke]

Just Accepted!
🗞️Real-world comparison of dual vs single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis

https://t.co/oJDImWOCBY

@Simona_Sacco_ @mattfos89 @RaffaeleOrnello @luciodanna2 @fededs00 @Eleonor32576320 @MicheleRomoli @ZiniAndrea @MlzZedde

[Simona Sacco @Simona_Sacco_]

Advancing our approach to migraine prevention requires high-quality, academically led clinical trials.

https://t.co/cmFwYzYXJj

@JCephalalgia @ihs_official

[Matteo Foschi @mattfos89]

Pragmatic trials can address important open questions in #migraine 🧠🤕prevention.. find all their potential applications in our call 📢 of action paper 📝 just published (open access) on @JCephalalgia
@univaq @Simona_Sacco_ @RaffaeleOrnello @fededs00

https://t.co/cYqqsWLFYA

[Raffaele Ornello @RaffaeleOrnello]

The TACTIC staff and its prize! SISC National congress, Turin @Simona_Sacco_ @fededs00 @ChiaraRosx @RobDeicco